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Abstract
Background: Interspecific recombinant viruses R1ΔgC and R2ΔgI were isolated after in vitro co-infection with
BoHV-1 and BoHV-5, two closely related alphaherpesviruses that infect cattle. The genetic characterization of R1ΔgC
and R2ΔgI showed that they are composed of different sections of the parental genomes. The aim of this study
was the characterization of the in vivo behavior of these recombinants in the natural host.
Results: Four groups of four 3-month-old calves of both genders were intranasally inoculated with either the
recombinant or parental viruses. A control group of two animals was also included. Viral excretion and clinical
signs were monitored after infection. Histopathological examination of the central nervous system (CNS) was
performed and the establishment of latency in trigeminal ganglia was analyzed by PCR. The humoral response was
also evaluated using ELISA tests.
Three out of four animals from the BoHV-5 infected group excreted virus for 4-10 days. Two calves shed R1ΔgC
virus for one day. In R2ΔgI and BoHV-1.2ΔgCΔgI groups, infectious virus was isolated only after two or three blind
passages. None of the infected animals developed neurological signs, although those infected with BoHV-5
showed histopathological evidence of viral infection. Latent viral DNA was detected in at least one calf from each
infected group. Serum and/or mucosal antibodies were detected in all groups.
Conclusion: Both BoHV-1/-5 recombinants and the BoHV-1 parental strain are attenuated in calves, although they
are able to replicate in animals at low rates and to establish latent infections.
Background
Bovine herpesviruses 1 (BoHV-1) and 5 (BoHV-5) are
two closely related alphaherpesviruses infecting cattle.
BoHV-1 respiratory infection is usually associated with
infectious bovine rhinotracheitis, abortion, and systemic
infection in neonates [1]. BoHV-5 infection induces
respiratory and nervous diseases, i.e. meningoencephali-
tis [2]. Both viruses are neurotropic and establish a life-
long latent infection in neurons of sensory ganglia [2,3].
BoHV-1 infection is present in all continents, although
there are differences in prevalence and incidence [4]. In
the USA, Canada, Australia and New Zealand the sero-
prevalence of BoHV-1 infection is variable but may be
very high. BoHV-1 is also present in European coun-
tries, where a variety of control programs are carried
out. Concerning South American countries, BoHV-1
infection is endemic and the seroprevalence is high [5].
On the other hand, BoHV-5 outbreaks are sporadic and
appear to be very restricted in their geographical distri-
bution, being mostly detected in the Southern hemi-
sphere [2]. In Argentina and Brazil, BoHV-1 and BoHV-
5 co-circulate and vaccination against BoHV-1 is not
obligatory. In addition, cattle co-infection has been
recently shown to exist [6]. In this context, in vivo
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occur.
Recombination is a frequent event among alphaher-
pesviruses, enhancing their diversity and modifying virus
replication properties in vivo [7]. Although the process
of interspecific recombination appears inefficient relative
to intraspecific recombination [8], a natural interspecies
recombinant virus between equid herpesviruses 1 (EHV-
1) and 4 (EHV-4) has been recently reported after ana-
lyzing EHV-1 field strains [9]. Both the recombinant
virus and the parental EHV-4 were found to be non-
neuropathogenic in the hamster model [9].
Regarding bovine alphaherpesviruses, two recombinant
viruses have been isolated from in vitro interspecific
recombination between a genetically modified strain of
BoHV-1 (BoHV-1.2ΔgCΔgI) and BoHV-5 strain N569
[8]. The genetic composition of these recombinants,
named R1ΔgC and R2ΔgI, has been published recently
[10]. R1ΔgC is composed mainly of BoHV-5 (63%)
whereas R2ΔgI is 86% homologous to BoHV-1 (Figure
1). Recombination could have a deep impact on BoHV-
1 and BoHV-5 pathogenesis and epidemiology since it
could lead to virulence restoration of attenuated strains
or to an increase in pathogenicity by acquisition of viru-
lence-associated genes. However, the consequences of
recombination on R1ΔgC and R2ΔgI in vivo behavior
have not been studied yet. The aim of this study was to
assess the in vivo behavior of two BoHV-1/-5 interspeci-
fic recombinant viruses in calves. This study constitutes
the first report on the evaluation of interspecific recom-
binants in the natural host.
Methods
Viruses and cell culture
The viruses used in this study are illustrated in Figure 1.
Viral stocks -with high number of passages- were kindly
provided by Virology and Immunology laboratory of
University of Liege. The viruses were propagated in
Madin Darby bovine kidney (MDBK, ATCC, USA) cells
at a low multiplicity of infection as previously described
[11]. Total DNA (viral and cell DNA) was prepared
from infected cells using an extraction buffer 2× (Tris
200 mM pH 8, EDTA 20 mM pH 8, NaCl 200 mM,
SDS 2%, 2-mercaptoethanol 20 mM) (Sigma-Aldrich,
USA) and precipitated by alcohol.
Animal experiments
Eighteen 3-month-old calves of both genders were ran-
domly separated in four groups of four animals each
and one control group of two animals. Their naïve sta-
tus for BoHV-1 and BoHV-5 exposure was verified by
an enzyme-linked immunosorbent assay (ELISA) and
seroneutralization assays (SN) [11] and virus isolation
from nasal samples upon arrival and before experimen-
tal infection. After infection, all groups were strictly iso-
lated from each other in order to prevent spread and
contamination with the different virus strains used. Ani-
mal care and experimental procedures were performed
in accordance with the requirements of the National
Institute of Agricultural Technology Ethics Committee
(INTA, Argentina).
Calves were infected intranasally (aerosolization) with
3 ml containing a total dose of 10
6.5 TCID50/ml (1.5 ml
in each nostril) of the corresponding viral strain. The
control group received 3 ml of cell culture medium.
Animals were examined both before the start of the
experience and daily after infection by a veterinarian
who was not aware of the treatment of individual ani-
mals. Respiratory and nervous signs and rectal tempera-
ture were recorded. Between days 35-37 post-infection
(pi) animals were sedated with acepromazine (Acedan,
Holliday Scott S.A., Argentina) by the intramuscular
route and then euthanized by barbiturate overdose
(Euthanyle, Brouwer, Argentina). Necropsy was per-
formed immediately and encephalon and trigeminal
ganglia were dissected.
Sampling procedure, serological and virological analysis
Blood samples were taken on the day of inoculation and
then weekly. Serum antibodies against BoHV-1 were
detected by using an indirect ELISA and by SN assays
[11].
Nasal samples were collected daily from day 0 to day
18 pi and then twice a week until the end of the experi-
ment and inoculated onto MDBK cell monolayers
Figure 1 Representation of the genetic background of the four
viruses inoculated in this study. Parental strains: wild-type BoHV-5
(N569 strain) and mutant BoHV-1ΔgCΔgI; interspecific recombinants:
R1ΔgC and R2ΔgI. The organization of the four genomes includes a
unique long (UL) and a unique short (US) sequence. The latter is
flanked by two repeated and inverted sequences (internal repeat, IR;
terminal repeat, TR). The parental BoHV-1 is a mutated strain in
which the genes encoding the glycoproteins gC (UL44) and gI
(US7) were replaced by sequences encoding fluorescent proteins
GFP and RFP respectively (labeled by large asterisks). The BoHV-5
and BoHV-1 sequences are represented by black or white lines and
rectangles respectively. The site of recombination in each
recombinant virus is represented by discontinuous lines.
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the Reed and Muench method. Three blind passages
were performed on negative samples. Parental and
recombinant viral strains were identified either by obser-
vation of infected cells with an epifluorescent micro-
scope or by PCR assays using total DNA extracted from
infected cells [10]. IgA antibodies in nasal secretions
were determined by ELISA as previously described [11].
Histopathology and detection of latent BoHV DNA in
trigeminal ganglia
Samples of CNS (olfactory, frontal, parietal and occipital
areas, thalamus, midbrain, pons, obex and cerebellum)
and trigeminal ganglion were fixed in 10% buffered for-
maline solution, embedded in paraffin, sectioned at 4
μm and stained with hematoxylin-eosin (H/E) for histo-
pathological examination.
Pieces of approximately 100 mg of trigeminal ganglion
stored at -70°C were digested and total DNA was
extracted using the QIAamp DNA Mini kit (Qiagen,
Tecnolab S.A., Argentina). Total DNA was subjected to
two PCR reactions [12,13] in order to examine the pre-
sence of viral DNA. PCR was also performed with a set
of primers generating a 250 bp fragment from the
bovine glyceraldehyde-3-phosphate dehydrogenase gene
(GAPDH), selected as the bovine housekeeping gene.
The primers were designated as GAPDH-For (5’-GCA
TCG TGG AGG GAC TTA TGA-3’)a n dG A P D H - R e v
(5’-GGG CCA TCC ACA GTC TTC TG-3’).
Results
Clinical and viral response after intranasal infection of
cattle
In order to study the in vivo behavior of the BoHV-1/-5
recombinant viruses R1ΔgC and R2ΔgI (Figure 1), two
groups of four animals were intranasally inoculated as
described in Materials and Methods. Two other groups
were infected accordingly with the parental strains,
BoHV-5 and BoHV-1.2ΔgCΔgI. A mock infected control
group of two animals was included.
Calves infected with R1ΔgC, R2ΔgI and parental
BoHV-1.2ΔgCΔgI viruses did not show clinical signs or
body temperature variations during the period studied
(Table 1).
Viral excretion was observed in three out of four ani-
mals from the BoHV-5 infected group for 4-10 days,
with peak titers of 4.3 to 5.3 log10 TCID50/ml. In con-
trast, the tested recombinants and parental BoHV-
1.2ΔgCΔgI displayed reduced in vivo replication capaci-
ties (Table 1). Two calves shed R1ΔgC virus for one day
with excretion titers of 2.3 and 2.5 log10 TCID50/ml,
respectively. Concerning the R2ΔgI and BoHV-
1.2ΔgCΔgI groups, infectious virus was isolated only
after two or three blind passages on cell cultures
infected with nasal swabs. The day of excretion onset
for each group was variable and is detailed in Table 1.
At least one positive isolate was observed in each group.
Post mortem analysis and establishment of latency
The histopathological examination performed in CNS
samples revealed a severe non-suppurative meningoen-
cephalitis in olfactory, frontal, parietal and occipital cor-
tex, thalamus, midbrain and cerebellum in two of the
BoHV-5-infected animals. Lesions were characterized by
perivascular infiltration of mononuclear cells (mostly
lymphocytes), focal gliosis and focal malacia (Figure 2).
In addition, three animals showed slight vascular altera-
tions in the trigeminal ganglion. In contrast, animals
infected with R1ΔgC, R2ΔgI and parental BoHV-
1.2ΔgCΔgI presented either slight or no histological
alterations in all the sections examined.
To investigate the establishment of latency by the dif-
ferent viruses, trigeminal ganglia were dissected after
euthanasia 35 days pi. PCR assays were performed to
Table 1 Viral excretion and humoral response after intranasal infection. Detection of viral DNA in trigeminal ganglia
(TG)
Acute phase Latent phase Humoral response
Group Nasal
excretion
a
Days post infection of excretion
onset
N° excreting
days
Viral DNA in
TG
b
Mucosal
IgA
c
Seroconversion
d
BHV-5 N569 3/4 2-7 4-10 2/4 3/4 3/4
BHV-1.2
ΔgCΔgI
1/4 5* 1 2/3 4/4 0/4
R1ΔgC 2/4 2-3 1 2/4 3/4 1/4
R2ΔgI 1/4 1* 1 1/4 1/4 0/4
Mock-infected 0/2 0 0 0/2 0/2 0/2
* Positive samples after 2-3 blind passages in cell culture.
a Number of excreting animals out of total animals in the group. Identity of excreted virus was confirmed by PCR and fluorescence microscopy.
b Number of trigeminal ganglia (TG) with viral DNA out of total TG available.
c Mucosal IgA raised toward BoHV-1/-5. Number of positive animals out of total animals in the group.
d Serum antibodies against BoHV-1/-5. Number of positive animals out of total animals in the group.
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DNA. In addition, trigeminal ganglia were co-cultured
with susceptible cells and monitored for BoHV replica-
tion. Since no cytopathic effect developed in the cul-
tures, we concluded that the positive PCR results (Table
1) were due to the presence of latent viral genomes. The
presence of viral DNA was observed in at least one calf
from each of the infected groups, thus indicating that
both the recombinant viruses and the parental strains
were able to establish a latent infection in trigeminal
ganglia.
Humoral immune response
The immune response specifically raised against BoHV-
1 and BoHV-5 after the experimental infection was mea-
sured either by ELISA or by the SN assay. Seroconver-
sion was detected in three out of the four BoHV-5-
infected animals as well as in one animal from the
R1ΔgC group (Table 1). Mucosal IgA was detected in
all the infected groups but not in mock-infected calves
(Table 1).
In summary, the data show that all the viruses were
able to replicate in calves although R1ΔgC, R2ΔgI and
parental BoHV-1.2ΔgCΔgI were attenuated in vivo.
Detectable virus excretion by animals infected with
these viruses was low and none of the infected animals
developed clinical signs during the experimental
infection.
Discussion
BoHV-1 and BoHV-5 have been shown to co-circulate
in nature and cattle co-infection has been recently
demonstrated [6]. Even if the process of interspecific
recombination appears inefficient relative to intraspecific
recombination, a natural interspecies recombinant virus
between EHV-1 and EHV-4 has been reported by ana-
lyzing EHV-1 field strains [9]. Therefore, BoHV-1 and
BoHV-5 may give rise to interspecific recombinants
with unknown biological characteristics in co-infected
cattle. Recombination may lead to virulence restoration
of attenuated strains or to a decrease in the pathogeni-
city of parental viruses. Regarding this, there are several
reports describing the generation of virulent HSV-1 and
PrV intraspecific recombinants [14,15] and avirulent
HSV-1/-2 interspecific recombinants [16].
The in vivo behavior of the in vitro-generated inter-
specific recombinant viruses between BoHV-1 and
BoHV-5 was investigated in the natural host. According
to our experimental data, after nasal infection of calves,
R1ΔgC and R2ΔgI are attenuated but able to replicate at
low rates and establish latent infections.
According to the genomic characterization performed
elsewhere [10] (Figure 1), most of the genomic back-
ground of R1Δg Cv i r u si sh o m o l o g o u st oB o H V - 5
(63%), including some of the genes associated with the
differential pathogenesis between BoHV-5 and BoHV-1
(US7-gI, US8-gE and US9) [2], whereas R2ΔgI virus is
86% homologous to BoHV-1. Despite their genomic
content, both recombinant viruses appear to be attenu-
ated in calves. This may suggest that the BoHV-5 genes
enclosed in the US region, the internal and terminal
repeats and part of the UL region are not able to confer
BoHV-5 in vivo replication properties to R1ΔgC in the
genetic background of the parental BoHV-1. However,
since the recombinant viruses were obtained by in vitro
co-infection between a highly attenuated BoHV-1 strain
(tested in this study) and BoHV-5, the evaluation of the
association between genetic composition and virulence
of these recombinants is limited. Although BoHV-5-
infected animals did not present neurological signs, viral
excretion and histopathological lesions were observed.
Animal age and individual susceptibility, among other
factors, could account for the absence of clinical signs
in the BoHV-5-infected group [2]. The histological
alterations found in the CNS samples from BoHV-5-
infected animals were similar to those reported after cat-
tle infection with other BoHV-5 strains [17,18]. The
slight lesions observed in both the recombinants and
parental BoHV-1 could be due to unspecific cellular
alterations.
Serum and/or mucosal antibodies were detected in all
groups, consistently with a previous report showing the
induction of nasal IgA in calves after infection with dif-
ferent BoHV-1 strains [19]. However, humoral response
was not detected in some animals. The low rate of viral
replication could account for the lack of induction of
immune response. In addition, the sensitivity of the
ELISA tests available could be insufficient to detect a
v e r yl o wa n t i b o d yr e s p o n s ee v o k e db yt h er e c o m b i n a n t
viruses.
The reduced virulence observed in the R1ΔgC and
R2ΔgI viruses could be attributed to the high attenua-
tion that the parental BoHV-1ΔgCΔgI has per se.
Indeed, different degrees of virulence have been
Figure 2 Histopathological lesions of a BoHV-5 infected calf.A )
Frontal lobe. Mononuclear inflammatory exudate in perivascular
cuff. Focal gliosis in white matter. H/E. Bar = 200 μm. B) Frontal
lobe. Detail of A: Numerous lymphocytes in perivascular cuff. H/E.
Bar = 100 μm.
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genetically modified [21] strains. A genetic characteriza-
tion of the two BoHV-1/-5 recombinants and parental
strains has been recently performed in the whole gen-
ome [10]. However, other genetic modifications intro-
duced during the generation of the parental double
deleted mutant or in the recombinant isolation process
could also account for their in vivo attenuation. More-
over, small modifications in viral genomes can have a
deep impact on the in vivo behavior. In this respect, var-
iation of a single amino acid in the polymerase of neu-
ropathogenic EHV-1 strains has been associated with
their neurovirulence [22].
The high in vivo attenuation that the two BoHV-1/5
recombinants showed in cattle indicates that these
recombinants might not constitute a major risk of per-
sistence and spread in cattle population. However, in
areas where co-infections with virulent strains of BoHV-
1 and BoHV-5 exists (Southern hemisphere) the genera-
tion of unknown virulence recombinants could occur.
Conclusion
In this study we investigated the in vivo behavior of two
interspecific recombinant viruses generated in vitro
from closely related alphaherpesviruses infecting the
same natural host. Although both recombinants showed
reduced virulence following experimental cattle infec-
tion, our results demonstrate in vivo replication and
establishment of latency of in vitro-generated BoHV-1/-
5 recombinants.
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